Is the new Wilson LIC, WAM Strategic Value (ASX:WAR) a buy?
Whilst WAM Capital has proven form using the underlying investment strategies planned for this new LIC, there are a few reasons why I would be cautious about jumping in. The performance fee is high, opportunities for this overall strategy have dried up somewhat compared to last year, and then there are the usual potential issues of buying LICs at IPO.
Continue reading “WHICH LICs WILL WAM GO TO WAR ON? WAM STRATEGIC VALUE REVIEW (ASX:WAR)”
Around late September it struck me that some investors buying WAM Capital (ASX:WAM) & WAM Leaders (ASX:WLE) may not have considered some alternatives. Was there potentially cheaper back door entries into these stocks available? Continue reading “WHICH WAM LEADERS TO FOLLOW, SPECIAL SITUATION INVESTING & APW”
I realise many of the readers here may already have come across this article from Daryl Wilson at Affluence Funds Management but felt it was worth a mention. This fund manager specialises in ASX LICs. I tend to agree with many of their views in articles I come across and this was no exception. I thought I would just comment further down about how some of the themes they brought up in the article may be impacting my own decision making. Continue reading “A good reminder on some themes to consider in LIC’s over the next year.”
Author’s note: In compiling this article I have used data as at 25th April, 2018.
Recently I was checking out Morphic Ethical Equities Fund (MEC) and observed how fickle the premium / discount to NTA can behave. It is almost one year since listing and this type of pattern I see quite often in new LICs. Continue reading “Investing in global LICs at IPO stage & brief thoughts on WAM Global.”